Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8794
Treatment of Pathologic Stage C Carcinoma of the Prostate with Adjuvant Radiotherapy
Research Committee(s)
Genitourinary Cancer
Activated
08-15-1988
Closed
01-01-1997
Closed
Phase
Accrual
25%
SWOG Clinical Trial Number
SWOG-8806
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Advanced Bladder Cancer (for patients not eligible for SWOG-8594)
Activated
08-15-1988
Closed
11-15-1990
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
SWOG-8850
Cisplatin and Novobiocin in the Treatment of Stage IV, Stage IIIb or Locally Recurrent Tumor After Radiation Therapy of Non-Small Cell Lung Cancer (NSCLC)
Activated
08-15-1988
Closed
06-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8500
Second-Line Treatment of Advanced Measurable Ovarian Cancer with CHIP
Activated
08-01-1988
Closed
11-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8742
Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Metastatic Sarcoma
Activated
08-01-1988
Closed
12-01-1989
Closed
Phase
Accrual
27%
SWOG Clinical Trial Number
SWOG-8744
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Multiple Myeloma
Activated
08-01-1988
Closed
11-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8723
Evaluation of Amonafide in Disseminated Malignant Melanoma
Activated
07-15-1988
Closed
06-01-1990
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8748
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8720
Evaluation of Amonafide in Pancreatic Adenocarcinoma
Activated
07-01-1988
Closed
07-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8805
Neoadjuvant Cisplatin and VP-16 Plus Concurrent Chest and Optional Brain Irradiation for Patients with Stage lll Non-Small Cell Lung Carcinoma
Research Committee(s)
Lung Cancer
Activated
07-01-1988
Closed
03-15-1992
Closed
Phase
Accrual
59%
Published
SWOG Clinical Trial Number
SWOG-8738
Treatment of Extensive Non-Small Cell Lung Cancer: Standard Dose Cisplatin Versus High-Dose Cisplatin in Hypertonic Saline Alone Versus High-Dose Cisplatin/Mitomycin-C
Research Committee(s)
Lung Cancer
Activated
07-01-1988
Closed
06-01-1990
Closed
Phase
Accrual
83%
Published
SWOG Clinical Trial Number
SWOG-8760
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Gastric Carcinoma
Activated
06-15-1988
Closed
01-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8755
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients With Pancreatic Adeno-carcinoma
Activated
06-15-1988
Closed
01-01-1990
Closed
Phase
Accrual
71%
Published
SWOG Clinical Trial Number
SWOG-8743
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients with Metastatic Colorectal Adenocarcinoma
Activated
06-15-1988
Closed
01-01-1990
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8717
Evaluation of Amonafide and Didemnin-B in the Treatment of Ovarian Cancer
Activated
05-15-1988
Closed
Phase
Accrual
57%
Published
SWOG Clinical Trial Number
SWOG-8726
Evaluation of Amonafide in Refractory Multiple Myeloma
Activated
04-01-1988
Closed
11-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8800
Evaluation of Pibenzimol in Advanced Pancreatic Adenocarcinoma
Activated
04-01-1988
Closed
05-01-1989
Closed
Phase
Accrual
69%
Published
SWOG Clinical Trial Number
SWOG-8711
A Study of Reproductive Function in Patients with Testicular Cancer
Research Committee(s)
Genitourinary Cancer
Activated
04-01-1988
Closed
06-01-1994
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8804
Evaluation of Cis-Platinum and DTIC in Inoperable Stage lll and Stage IV Melanoma
Activated
04-01-1988
Closed
06-01-1990
Closed
Phase
Accrual
30%
Published
SWOG Clinical Trial Number
SWOG-8803
A Six Course Alternating Combination Regimen in Advanced Previously Untreated Head and Neck Cancer Patients
Activated
04-01-1988
Closed
05-01-1990